Side-effects and risk profile of latanoprost 0.005% (Xalatan®);Nebenwirkungen und risiko-profil bei anwendung von latanoprost 0,005% (Xalatan®)

Ophthalmologe

Volumn 99, Issue 9, 2002, Pages 724-729

  Schlote, Torsten ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Hypertrichosis; Latanoprost; Macular edema; Pigmentation; Side effects; Uveitis

Indexed keywords

ANTIGLAUCOMA AGENT; LATANOPROST; MELANIN; PILOCARPINE; TIMOLOL; PROSTAGLANDIN F;

ARTICLE; CARDIOTOXICITY; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; EYELASH; EYELID; GLAUCOMA; HEADACHE; HERPES SIMPLEX VIRUS; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; INTRAOCULAR HYPERTENSION; RASH; RETINA MACULA EDEMA; UVEITIS; VIRUS INFECTION; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; EYELID DISEASE; RETINA MACULA CYSTOID EDEMA; RISK FACTOR;

DOSE-RESPONSE RELATIONSHIP, DRUG; EYELASHES; EYELID DISEASES; GLAUCOMA; HYPERPIGMENTATION; HYPERTRICHOSIS; MACULAR EDEMA, CYSTOID; PROSTAGLANDINS F, SYNTHETIC; RISK FACTORS; UVEITIS;

EID: 0036707589     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-002-0613-1     Document Type: Article

References (44)

1. Alm A, Stjernschantz J, the Scandinavian Latanoprost Study Group (1995) Effects on intraocular pressure and side effects of 0,005% latanoprost applied once daily, evening or morning. A comparison with timolol. -Ophthalmology 102:1743-1752
2. Alm A, Widengard I (2000) Latanoprost: experience of 2-year treatment in Scandinavia. Acta Ophthalmol (Scand) 78:71-76
3. Broadway DC, Grierson I, O'Brien C, Hitchings RA (1994) Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery. Arch Ophthalmol 112:1446-1454
4. Camras CB, Neely DG, Weiss EL (2000) Latanoprost-induced iris color darkening: a case report with long-term follow-up. J Glaucoma 9:95-98
5. Chiba T, Kashiwagi K, Kogure S et al. (2001) Iridal pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients. J Glaucoma 10:406-410
6. Demitsu T, Manabe M, Harima N, Sugiyama T, Yoneda K, Yamada N (2001) Hypertrichosis induced by latanoprost. J Am Acad Dermatol 44:721-723
7. Dutkiewicz R, Albert DM, Levin LA (2000) Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines. Exp Eye Res 70:563-569
8. Ektomatis P (2001) Herpes simplex dendritis keratitis after treatment with latanoprost for primary open angle glaucoma. Br J Ophthalmol 85:1008-1009
9. Fechtner RD, Khouri AS, Zimmerman TJ et al. (1998) Anterior uveitis associated with latanoprost. Am J Ophthalmol 126:37-41
10. Hara T (2001) Increased iris pigmentation after use of latanoprost in Japanese brown eyes (Abstract). Nippon Ganka Gakkai Zasshi 105:314-321
11. Hedner J, Everts B, Moller CS (1999) Latanoprost and respiratory function in asthmatic patients: randomized, double-masked, placebo-controlled crossover evaluation. Arch Ophthalmol 117:1305-1309
12. Kaufman HE, Varnell ED, Toshida H, Kanai A, Thompson HW, Bazan NG (2001) Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. Am J Ophthalmol 131:643-646
13. Kent AR, Vroman DT, Thomas TJ, Hebert RL, Crosson CE (1999) Interaction of pilocarpine with latanoprost in patients with glaucoma and ocular hypertension. J Glaucoma 8:257-262
14. Kook MS, Lee K (2000) Increased eyelid pigmentation associated with use of latanoprost. Am J Ophthalmol 129:804-806
15. Krohn J, Hove VK (1999) Iris cyst associated with topical administration of latanoprost. Am J Ophthalmol 127:91-93
16. Lark KK, Pasha AS, Yan X, Edward DP (1999) The effect of latanoprost and brimonidine on rabbit subconjunctival fibroblasts. J Glaucoma 8:72-76
17. Lass JH, Eriksson GL, Osterling L, Simpson CV, for the Latanoprost Corneal Effects Study Group (2001) Comparison of the corneal effects of latanoprost, fixed combination latanoprost-timolol, and timolol. A double-masked, randomized, one-year study. Ophthalmology 108:264-271
18. Johnstone MA (1997) Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 124:544-547
19. Mastropasqua L, Carpineto P. Ciancaglini M, Gallenga PE (1999) A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma. Ophthalmology 106:550-555
20. Mietz H, Schlötzer-Schrehardt U, Strassfeld C, Krieglstein GK (2001) Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci 42:679-687
21. Mitra M, Chang B, James T (2001) Exacerbation of angina associated with latanoprost. BMJ 323:783
22. Morales J, Shihab ZM, Brown SM, Hodges MR (2001) Herpes simplex virus dermatitis in patients using latanoprost. Am J Ophthalmol 132:114-116
23. Moroi SE, Gottfredsdottir MS, Schteingart MT et al. (1999) Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 106:1024-1029
24. Prota G, Vincensi MR, Napolitano A, Selen G, Stjernschantz J (2000) Latanoprost stimulates eumelanogenesis in iridal melanocytes of cynomolgus monkeys. Pigment Cell Res 13:147-150
25. Rowe JA, Hattenhauer MG, Herman DC (1997) Adverse side effects associated with latanoprost. Am J Ophthalmol 124:683-685
26. Sacca S, Pascotto A, Siniscalchi C, Rolando M (2001) Ocular complications of latanoprost in uveitic glaucoma: three reports. J Ocul Pharmacol Ther 17:107-113
27. Schumer RA, Camras CB, Mandahl AK (2000) Latanoprost and cystoid macular edema: is there a causal relation? Curr Opin Ophthalmol 11:94-100
28. Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC (1999) Latanoprost 0,005% and anterior uveitis. Acta Ophthalmol (Scand) 77:668-672
29. Stewart O, Walsh L, Pande M (1999) Bilateral optic disc oedema associated with latanoprost. Br J Ophthalmol 83:1092-1093
30. 2α-Isopropylester to latanoprost: a review of the development of Xalatan: the Proctor Lecture. Inv Ophthalmol Vis Sci 42:1134-1145
31. Thygesen J, Aaen K, Theodorsen F, Kessing SV, Prause JU (2000) Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension. Acta Ophthalmol (Scand) 78:37-44
32. 2α analog, on aqueous humor dynamics in human eyes. Ophthalmology 100:1297-1304
33. Veyrac G, Chiffoleau A, Cellerin L, Larousse C, Bourin M (1999) Latanoprost (Xalatan) and a systemic respiratory effect? Apropos a case. Therapie 54:494-496
34. Waheed K, Laganowski H (2001) Bilateral poliosis and granulomatous anterior uveitis associated with latanoprost use and apparent hypotrichosis on its withdrawl. Eye 15:347-349
35. Wand M (1997) Latanoprost and hyperpigmentation of eyelashes. Arch Ophthalmol 115:1206-1207
36. Wand M, Gilbert CM, Liesegang TJ (1999) Latanoprost and herpes simplex keratitis. Am J Ophthalmol 127:531-536
37. Wand M, Ritch R, Isbey EK, Zimmerman TJ (2001) Latanoprost and periocular skin color changes. Arch Ophthalmol 119:614-615
38. Wand M, Gaudio AR, Shields MB (2001) Latanoprost and cystoid macular edema in high-risk aphakic and pseudophakic eyes. J Cataract Refract Surg 27:1397-1401
39. Warwar RE, Bullock JD, Ballal D (1998) Cystoid macular edema and anterior uveitis associated with latanoprost use. Ophthalmology 105:263-268
40. Watson P, Stjernschantz J, the Latanoprost Study Group (1996) A six-months, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 103:126-137
41. Watson PG, the Latanoprost Study Group (1998) Latanoprost. Two years' experience of its use in the United Kingdom. Ophthalmology 105:82-87
42. Weston BC (2001) Migraine headache associated with latanoprost. Arch Ophthalmol 119:300-301
43. Wistrand PJ, Stjernschantz J, Olsson K (1997) The incidence and time-course of latanoprost-induced iridal pigmentation as a function of eye color. Surg Ophthalmol 41 (Clinical trial):S129-S138
44. Zhang WY, Po AL, Dua HS, Azuara-Blanco A (2001) Meta-analysis of randomised controlled trial comparing latanoprost with timolol in the treatment of patients with open angle glaucoma and ocular hypertension. Br J Ophthalmol 85:983-990